These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 21659416)

  • 21. Matrix metalloproteinase 12 silencing: a therapeutic approach to treat pathological lung tissue remodeling?
    Garbacki N; Di Valentin E; Piette J; Cataldo D; Crahay C; Colige A
    Pulm Pharmacol Ther; 2009 Aug; 22(4):267-78. PubMed ID: 19327406
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Matrix-Metallo-Proteinases and their tissue inhibitors in radiation-induced lung injury.
    Yang K; Palm J; König J; Seeland U; Rosenkranz S; Feiden W; Rübe C; Rübe CE
    Int J Radiat Biol; 2007 Oct; 83(10):665-76. PubMed ID: 17729161
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Matrix metalloproteinase-2 (MMP-2) and MMP-9 in pulmonary pathology.
    Chakrabarti S; Patel KD
    Exp Lung Res; 2005; 31(6):599-621. PubMed ID: 16019990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of MMP-7, MMP-9, TIMP-1 and TIMP-2 mRNA in lung tissue of patients with non-small cell lung cancer (NSCLC) and benign pulmonary disease.
    Safranek J; Pesta M; Holubec L; Kulda V; Dreslerova J; Vrzalova J; Topolcan O; Pesek M; Finek J; Treska V
    Anticancer Res; 2009 Jul; 29(7):2513-7. PubMed ID: 19596921
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Curcumin: a potential candidate for matrix metalloproteinase inhibitors.
    Kumar D; Kumar M; Saravanan C; Singh SK
    Expert Opin Ther Targets; 2012 Oct; 16(10):959-72. PubMed ID: 22913284
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Matrix metalloproteinase-9/gelatinase B is a putative therapeutic target of chronic obstructive pulmonary disease and multiple sclerosis.
    Muroski ME; Roycik MD; Newcomer RG; Van den Steen PE; Opdenakker G; Monroe HR; Sahab ZJ; Sang QX
    Curr Pharm Biotechnol; 2008 Feb; 9(1):34-46. PubMed ID: 18289055
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depsipeptide a histone deacetlyase inhibitor down regulates levels of matrix metalloproteinases 2 and 9 mRNA and protein expressions in lung cancer cells (A549).
    Vinodhkumar R; Song YS; Ravikumar V; Ramakrishnan G; Devaki T
    Chem Biol Interact; 2007 Feb; 165(3):220-9. PubMed ID: 17240363
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MMP inhibitors and cancer treatment trials, limitations and hopes for the future.
    Tlatli R; El Ayeb M
    Arch Inst Pasteur Tunis; 2013; 90(1-4):3-21. PubMed ID: 26012207
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Matrix metalloproteinases and their inhibitors in non-neoplastic otorhinolaryngological disease.
    De S; Fenton JE; Jones AS
    J Laryngol Otol; 2005 Jun; 119(6):436-42. PubMed ID: 15992468
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Simultaneous up-regulation of matrix metalloproteinases 1, 2, 3, 7, 8, 9 and tissue inhibitors of metalloproteinases 1, 4 in serum of patients with chronic obstructive pulmonary disease.
    Navratilova Z; Zatloukal J; Kriegova E; Kolek V; Petrek M
    Respirology; 2012 Aug; 17(6):1006-12. PubMed ID: 22591289
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metalloproteases/anti-metalloproteases imbalance in chronic obstructive pulmonary disease: genetic factors and treatment implications.
    Mocchegiani E; Giacconi R; Costarelli L
    Curr Opin Pulm Med; 2011 Dec; 17 Suppl 1():S11-9. PubMed ID: 22209925
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Smooth muscle cell matrix metalloproteinases in idiopathic pulmonary arterial hypertension.
    Lepetit H; Eddahibi S; Fadel E; Frisdal E; Munaut C; Noel A; Humbert M; Adnot S; D'Ortho MP; Lafuma C
    Eur Respir J; 2005 May; 25(5):834-42. PubMed ID: 15863640
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Concentrations of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinases-1 in serum of patients with chronic obstructive pulmonary disease].
    Piesiak P; Brzecka A; Kosacka M; Passowicz-Muszyńska E; Dyła T; Jankowska R
    Pol Merkur Lekarski; 2011 Nov; 31(185):270-3. PubMed ID: 22299526
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression of matrix metalloproteinases 1, 2, 9 and their tissue inhibitors in stage II non-small cell lung cancer: implications for MMP inhibition therapy.
    Pritchard SC; Nicolson MC; Lloret C; McKay JA; Ross VG; Kerr KM; Murray GI; McLeod HL
    Oncol Rep; 2001; 8(2):421-4. PubMed ID: 11182067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MMP-9 protein level does not reflect overall MMP activity in the airways of patients with COPD.
    Lowrey GE; Henderson N; Blakey JD; Corne JM; Johnson SR
    Respir Med; 2008 Jun; 102(6):845-51. PubMed ID: 18328682
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Matrix metalloproteinase 11 (MMP-11; stromelysin-3) and synthetic inhibitors.
    Matziari M; Dive V; Yiotakis A
    Med Res Rev; 2007 Jul; 27(4):528-52. PubMed ID: 16710861
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Matrix metalloproteinases in acute lung injury: mediators of injury and drivers of repair.
    Davey A; McAuley DF; O'Kane CM
    Eur Respir J; 2011 Oct; 38(4):959-70. PubMed ID: 21565917
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Role of Neutrophil Elastase Inhibitors in Lung Diseases.
    Polverino E; Rosales-Mayor E; Dale GE; Dembowsky K; Torres A
    Chest; 2017 Aug; 152(2):249-262. PubMed ID: 28442313
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Superoxide dismutases in the lung and human lung diseases.
    Kinnula VL; Crapo JD
    Am J Respir Crit Care Med; 2003 Jun; 167(12):1600-19. PubMed ID: 12796054
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HGF reduces advancing lung fibrosis in mice: a potential role for MMP-dependent myofibroblast apoptosis.
    Mizuno S; Matsumoto K; Li MY; Nakamura T
    FASEB J; 2005 Apr; 19(6):580-2. PubMed ID: 15665032
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.